David Grinblatt to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications David Grinblatt has written about Antimetabolites, Antineoplastic.
Connection Strength
0.237
-
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies. Oncologist. 2018 02; 23(2):159-170.
Score: 0.132
-
Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA registry. Leuk Lymphoma. 2015 Apr; 56(4):887-95.
Score: 0.106